Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Clinical Trial of Mirabegron for Overactive Bladder Symptoms in Patients With Parkinson Disease and Impaired Cognition

NCT02536976 is registered in ClinicalTrials.gov with HealthPartners Institute as lead sponsor.

NCT NCT02536976
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02536976 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Clinical Trial of Mirabegron for Overactive Bladder Symptoms in Patients With Parkinson Disease and Impaired Cognition
Lead sponsor
HealthPartners Institute
Phase
Phase 4
Overall status
Completed
Start date
December 31, 2015
Completion date
August 1, 2018
Enrollment
7 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

impaired cognition, overactive bladder, parkinson disease